
Thomas C. Mckenzie
Examiner (ID: 6300)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1625, 1624, 1611 |
| Total Applications | 744 |
| Issued Applications | 514 |
| Pending Applications | 94 |
| Abandoned Applications | 135 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6439864
[patent_doc_number] => 20020128269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Substituted heterocyclic compounds for treating multidrug resistance'
[patent_app_type] => new
[patent_app_number] => 09/740387
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15304
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128269.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740387
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740387 | Substituted heterocyclic compounds for treating multidrug resistance | Dec 18, 2000 | Abandoned |
Array
(
[id] => 6082551
[patent_doc_number] => 20020082262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Substituted bicyclic compounds for treating multidrug resistance'
[patent_app_type] => new
[patent_app_number] => 09/740642
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14218
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082262.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740642 | Substituted bicyclic compounds for treating multidrug resistance | Dec 18, 2000 | Abandoned |
Array
(
[id] => 5923275
[patent_doc_number] => 20020115659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance'
[patent_app_type] => new
[patent_app_number] => 09/740644
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12112
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115659.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740644
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740644 | Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance | Dec 18, 2000 | Abandoned |
Array
(
[id] => 1107962
[patent_doc_number] => 06809093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-26
[patent_title] => '2-substituted heterocyclic compounds'
[patent_app_type] => B2
[patent_app_number] => 09/741272
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14188
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/809/06809093.pdf
[firstpage_image] =>[orig_patent_app_number] => 09741272
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/741272 | 2-substituted heterocyclic compounds | Dec 18, 2000 | Issued |
Array
(
[id] => 1231728
[patent_doc_number] => 06693099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-17
[patent_title] => 'Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance'
[patent_app_type] => B2
[patent_app_number] => 09/740391
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15829
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 524
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/693/06693099.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740391
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740391 | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance | Dec 18, 2000 | Issued |
Array
(
[id] => 1413470
[patent_doc_number] => 06525000
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Method for producing anellated triazoles and new anellated triazoles and their use'
[patent_app_type] => B1
[patent_app_number] => 09/719812
[patent_app_country] => US
[patent_app_date] => 2000-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19640
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525000.pdf
[firstpage_image] =>[orig_patent_app_number] => 09719812
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/719812 | Method for producing anellated triazoles and new anellated triazoles and their use | Dec 17, 2000 | Issued |
Array
(
[id] => 941322
[patent_doc_number] => 06969713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-29
[patent_title] => 'Piperidine and piperazine acetamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/168094
[patent_app_country] => US
[patent_app_date] => 2000-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36090
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/969/06969713.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168094 | Piperidine and piperazine acetamide derivatives | Dec 17, 2000 | Issued |
Array
(
[id] => 6876813
[patent_doc_number] => 20010006966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action'
[patent_app_type] => new-utility
[patent_app_number] => 09/737741
[patent_app_country] => US
[patent_app_date] => 2000-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5720
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20010006966.pdf
[firstpage_image] =>[orig_patent_app_number] => 09737741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/737741 | Use of 1-(aminoalkyl)-3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action | Dec 17, 2000 | Issued |
Array
(
[id] => 6805439
[patent_doc_number] => 20030232833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Benzofuran derivatives'
[patent_app_type] => new
[patent_app_number] => 10/148658
[patent_app_country] => US
[patent_app_date] => 2002-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30284
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148658 | Benzofuran derivatives | Dec 5, 2000 | Issued |
Array
(
[id] => 5874764
[patent_doc_number] => 20020049201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Sulfonamide inhibitors of aspartyl protease'
[patent_app_type] => new
[patent_app_number] => 09/731129
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73748
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049201.pdf
[firstpage_image] =>[orig_patent_app_number] => 09731129
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/731129 | Sulfonamide inhibitors of aspartyl protease | Dec 5, 2000 | Issued |
Array
(
[id] => 6962054
[patent_doc_number] => 20010012893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-09
[patent_title] => 'Acyclovir diester derivatives'
[patent_app_type] => new
[patent_app_number] => 09/731256
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8439
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20010012893.pdf
[firstpage_image] =>[orig_patent_app_number] => 09731256
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/731256 | Acyclovir diester derivatives | Dec 5, 2000 | Abandoned |
Array
(
[id] => 1197064
[patent_doc_number] => 06727257
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => '5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines'
[patent_app_type] => B1
[patent_app_number] => 09/730458
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47735
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/727/06727257.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730458
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730458 | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines | Dec 4, 2000 | Issued |
Array
(
[id] => 1261754
[patent_doc_number] => 06664252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-16
[patent_title] => '4-aminopyrrolo2,3-dpyrimidine compounds specific to adenosine A2a receptor and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 09/728607
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39380
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664252.pdf
[firstpage_image] =>[orig_patent_app_number] => 09728607
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/728607 | 4-aminopyrrolo2,3-dpyrimidine compounds specific to adenosine A2a receptor and uses thereof | Nov 30, 2000 | Issued |
Array
(
[id] => 1115958
[patent_doc_number] => 06800633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-05
[patent_title] => 'Pyrrolo2,3dpyrimidine compositions and their use'
[patent_app_type] => B2
[patent_app_number] => 09/728229
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34404
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800633.pdf
[firstpage_image] =>[orig_patent_app_number] => 09728229
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/728229 | Pyrrolo2,3dpyrimidine compositions and their use | Nov 30, 2000 | Issued |
Array
(
[id] => 1404343
[patent_doc_number] => 06534505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-18
[patent_title] => 'Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same'
[patent_app_type] => B2
[patent_app_number] => 09/728497
[patent_app_country] => US
[patent_app_date] => 2000-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 6760
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534505.pdf
[firstpage_image] =>[orig_patent_app_number] => 09728497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/728497 | Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same | Nov 29, 2000 | Issued |
Array
(
[id] => 6017069
[patent_doc_number] => 20020103211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'TRICYCLIC FUSED XANTHINE COMPOUNDS AND THEIR USES'
[patent_app_type] => new
[patent_app_number] => 09/725016
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22863
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09725016
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/725016 | Tricyclic fused xanthine compounds and their uses | Nov 28, 2000 | Issued |
| 09/763569 | Process for preparing crystalline salts of amoxycillin | Nov 27, 2000 | Abandoned |
Array
(
[id] => 1446898
[patent_doc_number] => 06369066
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Substituted 1,3-oxathiolanes with antiviral properties'
[patent_app_type] => B1
[patent_app_number] => 09/722639
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14121
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369066.pdf
[firstpage_image] =>[orig_patent_app_number] => 09722639
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/722639 | Substituted 1,3-oxathiolanes with antiviral properties | Nov 27, 2000 | Issued |
Array
(
[id] => 1392467
[patent_doc_number] => 06544977
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'CRYSTALLINE FORMS OF 1S-1-ALPHA(2S*,3R*), 9ALPHA6, 10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9(1-ISOQUINOLYL)CARBONYLAMINOOCTAHYDRO-6H-PYRIDAZINO 1,2-A 1,2 DIAZEPIN-1-CARBOXAMIDE'
[patent_app_type] => B1
[patent_app_number] => 09/647858
[patent_app_country] => US
[patent_app_date] => 2000-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2440
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/544/06544977.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647858 | CRYSTALLINE FORMS OF 1S-1-ALPHA(2S*,3R*), 9ALPHA6, 10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9(1-ISOQUINOLYL)CARBONYLAMINOOCTAHYDRO-6H-PYRIDAZINO 1,2-A 1,2 DIAZEPIN-1-CARBOXAMIDE | Nov 19, 2000 | Issued |
| 09/716961 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Nov 19, 2000 | Abandoned |